What is Nasal Decongestant Market?
Nasal decongestants are the medicines used to reduce the symptoms of a blocked or stuffy nose caused by infection (such as the common cold, flu) or other breathing illnesses (such as hay fever, allergies, bronchitis). They help to treat congestion associate with upper respiratory infections (URIs), such as the common cold, and flu, allergic rhinitis, or hay fever, rhinosinusitis, and nasal polyps. The factors such as Increased Prevalence of Allergies among People, Increased Awareness about the Effectiveness of Nasal Decongestant and Rise in the Number of Hospitals and Clinics are driving the global Nasal Decongestant market. Also, the Increased Number of Online Pharmacies fueling the market growth. However, Not Very Effective to Reduce Symptoms and Risk of Addiction if Taken for Longer Time are the factors that may restrain the market growth.
The market study is being classified by Type (Phenylephrine, Pseudoephedrine, Intranasal Decongestants, Intranasal Corticosteroids and Antihistamines), by Application (Sinusitis, Cold, Rhinitis and Nasal Allergies) and major geographies with country level break-up.
Abbott Laboratories (United States), GlaxoSmithKline plc (United Kingdom), Cipla Limited (India), Bayer AG (Germany), Adapt Pharma (United States), Cadila Healthcare (India), Nidda Healthcare Holding GmbH (Germany), Procter and Gamble (United States), Transo-Pharm Handels-GmbH (Germany) and Sun Pharmaceutical Industries Ltd. (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Taj Pharmaceuticals (India) and McNeil Consumer Healthcare (United States).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Nasal Decongestant market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Nasal Decongestant market by Type, Application and Region.
On the basis of geography, the market of Nasal Decongestant has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Allergies among People
- Increased Awareness about Effectiveness of Nasal Decongestant
- Rise in the Number of Hospitals and Clinics
- Increased Number of Online Pharmacies
- Growing Demand for Nasal Decongestant from Asia
- Not Very Effective to Reduce Symptoms
- Risk of Addiction if Taken for Longer Time
- Growing Target Patient Population
- Development of Healthcare Infrastructure in Emerging Economies such as India and China
- Stringent Government Rules and Regulations
Market Leaders and some development strategies
Recently, Abbott has completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. It will strengthen the company's leadership while offering innovative products to address more areas of care.
In November 2020, Cipla Health has expanded its product portfolio with Naselin, a nasal decongestant spray. Naselin helps individuals get quick relief from a blocked nose caused by cold and allergy, which often results in disturbed sleep patterns, hampering overall productivity.
Key Target AudienceNasal Decongestant Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase